Lab
Dahl Chase Diagnostic Services
Dahl Chase Diagnostic Services was paid $1.32M by Medicaid between Jan 2018 and Dec 2024, across 12 billing codes. Its largest line is 87624, Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types — 36% of everything it billed.
33Billing provider infoDAHL CHASE DIAGNOSTIC SERVICES
BANGOR, ME 04401
BANGOR, ME 04401
33aNPI1104847110assigned 07/22/2006
33bProvider typeClinical Medical Laboratory
28Total paid$1.32M
24GClaims59,530
24DCodes billed12
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Maine
Rank by total paid#4 of 10
Median peer was paid$404K
This provider vs. median3.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,352 | $149K | |
| 2019 | 8,763 | $181K | |
| 2020 | 8,489 | $186K | |
| 2021 | 13,339 | $278K | |
| 2022 | 6,641 | $170K | |
| 2023 | 6,781 | $177K | |
| 2024incomplete | 7,165 | $180K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 36% | 22,055 | 20,956 | $471K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 29% | 12,241 | 11,206 | $379K |
| 88142 | 21% | 15,947 | 14,974 | $278K | |
| 88342 | 4.1% | 1,465 | 1,366 | $54K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 2.7% | 1,672 | 1,520 | $36K |
| 88312 | 2.1% | 700 | 637 | $28K | |
| 88304 | 1.9% | 1,086 | 1,013 | $25K | |
| 88112 | 1.4% | 1,133 | 924 | $18K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.2% | 626 | 602 | $15K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.2% | 626 | 602 | $15K |
| G0476 | Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test | 0% | 960 | 861 | $0.00 |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | 0% | 1,019 | 936 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSWANSON, SHARON (EXECUTIVE VICE PRESIDENT)
Parent organizationDAHL-CHASE PATHOLOGY ASSOC.